/ /

  • linkedin
  • Increase Font
  • Sharebar

    5 things you missed at SECO 2017 in Atlanta


    Johnson & Johnson Vision Care unveils toric daily contact lenses

    Johnson & Johnson Vision Care (JJVC) launched Acuvue Oasys 1-Day for Astigmatism contact lenses. The lenses feature the company’s Blink-Stabilized design along with its HydraLuxe technology that aids in vision quality and comfort, according to the company.

    “We set out to create a better contact lens option for patients with astigmatism, bringing together our best technologies in material and design for a lens that provides clear, stable vision with the exceptional comfort people have come to expect from the Acuvue Oasys family,” says Giovanna E. Olivares, OD, global astigmatism platform director at Johnson & Johnson Vision Care, Inc.

    Acuvue Oasys 1-Day for Astigmatism also provides Class I UVA and UVB protection.

    Related: 10 tips to better manage millennials

    CooperVision announces daily toric lens now available in 90-pack

    CooperVision, Inc. announced the availability of a 90-pack configuration for clariti 1 day toric contact lenses.

    “The one-day contact lens category continues to grow as a whole, and increasingly, eyecare professionals are choosing silicone hydrogel for their one-day patients,” says Inga Grote-Ebbs, director, one-day brands for CooperVision.

    CooperVision, Inc. says the addition of the 90-pack cartons enables ECPs to prescribe up to a three-month supply in one box similar to astigmatism patients which is a convenience they are accustomed to with other lenses.

    Related: Optometry must adapt to evolving AI

    Giovanni Castelli
    Giovanni Castelli is the content specialist for Optometry Times. He is a 2014 graduate of Cleveland State University with a degree in ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V